This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
BACE1 / Beta-secretase 1 · IHC design guide
Design Immunohistochemistry for BACE1
Plan paraffin section BACE1 staining around the granular cytoplasmic pattern reported across several tissues (HPA tissue IHC). Use the IHC validated antibody and compare positive tissue with a low staining control, while treating staining intensity cautiously because antibody staining and RNA expression have low consistency (HPA tissue IHC).
Evidence assembled Oct 2026 · For research use; verify linked source records and product datasheet before use
BACE1 Immunohistochemistry Experimental Design Guide
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before staining
| Expected localisation | Granular cytoplasm (HPA tissue IHC); TGN expected (UniProt) | |
| Staining pattern | Granular cytoplasmic staining in several tissues (HPA tissue IHC) | |
| Antigen retrieval | Citrate pH 6 HIER, heat-mediated (datasheet A00322) | |
| Positive control | Cerebellum+4 more · see all | |
| Negative control | Adipose tissue+4 more · see all |
Important caveats
Reasons your staining may differ from the expected pattern.
| Fixation | Use consistent formaldehyde fixation (datasheet A00322 IHC). (selected-SKU IHC image A00322) | |
| Caveat | Staining has low consistency with RNA expression (HPA tissue IHC) | |
| Regulation | Higher expression in brain and pancreas (UniProt) | |
| Isoform / epitope | 6 isoforms; map the epitope to its extracellular or cytoplasmic side (UniProt) |
Section 1
Recommended BACE1 IHC & IF Protocols
Compare the catalog antibody’s IHC-P protocol (datasheet A00322) with three published BACE1 IHC protocols (PMC4829010; PMC6073981; PMC10969905).
| Sample | Formaldehyde-fixed, paraffin-embedded human liver tissue (datasheet A00322) |
| Fixation | Image formalin-fixed; duration unreported (datasheet A00322); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: Citrate pH 6 (datasheet A00322); 20 min, 95–100 °C (standard) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% serum (datasheet A00322) |
| Primary antibody | Rabbit anti-BACE1, 1-2 μg/mL (datasheet A00322) |
| Primary incubation | Overnight at 4 °C (standard) |
| Detection | HRP-polymer secondary, DAB chromogen 5–10 min (standard) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | BACE1-positive staining in gLUC cells - cytoplasm/membrane of cerebellum (HPA tissue IHC: High). HPA tissue profile: Granular cytoplasmic expression in several tissues. No signal in the no-primary control. |
💡Decision noteFor paraffin sections, start with heat-mediated citrate retrieval at pH 6 (datasheet A00322); the paraffin-section study also used citrate at pH 6 (PMC10969905).
Section 2
What Is the Expected BACE1 Staining Pattern?
BACE1 is a membrane protein concentrated in the trans-Golgi network, with smaller pools in endosomes and at the cell surface (UniProt P56817 topology/localization). In paraffin IHC, expect granular cytoplasmic staining in selected cells, especially cerebellar GLUC cells; cortical neurons and caudate glia show medium staining (HPA tissue IHC). Interpret these patterns cautiously: HPA rates tissue staining Approved but reports low consistency with RNA expression (HPA tissue IHC reliability).
| Granular cytoplasmic staining in cerebellar GLUC cells, with some membrane-associated staining. | This matches HPA's high cerebellar GLUC-cell cytoplasm/membrane signal and its broader granular cytoplasmic tissue profile (HPA tissue IHC). Intracellular membrane-associated staining is plausible given BACE1 localization to the trans-Golgi network and endosomes (UniProt P56817 localization). Compare cells and compartments within the section before scoring intensity. |
| Moderate granular signal in cortical neurons or caudate glial cells. | These are documented medium-staining cell populations (HPA tissue IHC). A weaker result than cerebellar GLUC-cell staining can therefore fit the reference pattern (HPA tissue IHC). Record the stained cell population as well as intensity; a tissue-wide score alone can hide a mismatch in cell distribution. |
| Strong nuclear staining dominates otherwise identifiable cells. | A dominant nuclear pattern does not fit the supplied BACE1 locations: HPA describes granular cytoplasmic tissue staining, while UniProt lists membrane-associated compartments (HPA tissue IHC; UniProt P56817 localization). Treat it as suspect assay signal and review controls and detection conditions (general IHC practice); appearance alone cannot identify its cause. |
| Strong staining occurs in adipocytes, smooth muscle, or thyroid glandular cells. | HPA reports BACE1 as not detected in those cell populations (HPA tissue IHC). Reproducible staining there raises concern for cross-reactivity or endogenous detection activity, especially if compartment and morphology also disagree (general IHC practice). Because the HPA tissue profile has low RNA concordance, use these as comparison tissues, not absolute biological exclusions (HPA reliability). |
| Diffuse staining covers cells and surrounding tissue without a discernible granular pattern. | This does not resemble HPA's granular cytoplasmic profile (HPA tissue IHC). Background from detection reagents, inadequate blocking, or concentrated antibody can obscure the expected pattern (general IHC practice). Judge specificity only after checking a no-primary control and whether the signal resolves to the documented cell populations (general IHC practice). |
💡Expected BACE1 appearanceA convincing positive shows high granular cytoplasmic, sometimes membrane-associated, staining in cerebellar GLUC cells, with medium signal possible in cortical neurons or caudate glia; diffuse tissue-wide or dominant nuclear color is suspect (HPA tissue IHC; UniProt P56817 localization).
| Tissue and cell selection | Use cerebellar GLUC cells as a high-staining reference; cortical neurons and caudate glia are medium, while adipocytes and smooth muscle cells are reported not detected (HPA tissue IHC). The cell type matters more than a whole-section average when comparing these references (HPA tissue IHC). |
| Antibody evidence | CAB016358 has Approved IHC validation, while HPA flags low consistency between tissue staining and RNA expression (HPA antibody validation; HPA tissue IHC reliability). Agreement with the reported pattern supports interpretation but does not, by itself, prove that every stained cell contains BACE1. |
| Epitope position and processing | BACE1 has an extracellular region at residues 22–457, a transmembrane segment at 458–478, and a cytoplasmic tail at 479–501; its signal peptide and propeptide are processed (UniProt P56817 topology/processing). Without an antibody epitope map, the effect of these features on this assay cannot be specified. |
| Intracellular distribution | UniProt places most BACE1 in later Golgi/trans-Golgi compartments and smaller portions in the ER, endosomes, and cell surface (UniProt P56817 localization). This supports evaluating granular intracellular signal together with cell-associated membrane signal; paraffin chromogenic IHC does not identify an individual organelle from color alone (general IHC practice). |
| IF/ICC Q: Should its signal match paraffin IHC? | HPA reports supported plasma-membrane localization in ICC-IF, with images from A-431 and U-251MG; its tissue IHC profile is granular cytoplasmic (HPA subcellular ICC-IF; HPA tissue IHC). Compare each assay with its own HPA reference rather than requiring identical apparent compartments. |
| Situation | Likely cause | Next action |
|---|---|---|
| No staining in cerebellar GLUC cells. | The expected high signal is absent (HPA tissue IHC); the result alone does not distinguish sample biology from an IHC workflow failure (general IHC practice). | Check tissue identity, the IHC-validated antibody and its stated conditions, retrieval, detection reagents, and a known-working positive section (general IHC practice). Avoid assigning a BACE1-specific fixation effect without supporting evidence. |
| Signal appears mainly nuclear. | Nuclear dominance conflicts with HPA's granular cytoplasmic pattern and UniProt's membrane-associated locations (HPA tissue IHC; UniProt P56817 localization). | Review morphology and the no-primary control, then reassess antibody and detection conditions (general IHC practice). Do not score nuclear color as expected BACE1 staining. |
| Color appears in HPA not-detected cell populations. | Adipocytes, smooth muscle cells, and thyroid glandular cells are reported not detected (HPA tissue IHC); cross-reactivity or endogenous detection activity is possible (general IHC practice). | Compare the suspicious cells with a no-primary control and documented positive cells on a matched run (general IHC practice). Treat HPA's low RNA concordance as a limit on declaring any individual cell definitively negative (HPA reliability). |
| The entire section has diffuse color. | Diffuse color can obscure HPA's granular pattern; concentrated primary antibody, inadequate blocking, or detection background are general possibilities (HPA tissue IHC; general IHC practice). | Inspect a no-primary control, optimize blocking and washing, and titrate antibody within its stated IHC conditions (general IHC practice). Reassess whether signal resolves to the documented cells. |
| Only a sharp cell-edge signal is visible in tissue IHC. | Plasma-membrane localization is supported in ICC-IF, while tissue IHC is described as granular cytoplasmic (HPA subcellular ICC-IF; HPA tissue IHC). | Check for granular signal in the expected tissue cells and compare assay-specific HPA patterns (HPA tissue IHC; HPA subcellular ICC-IF). Review controls if edge staining is widespread (general IHC practice). |
| Medium-staining reference tissue looks weaker than cerebellum. | Cortical neurons and caudate glia are reported medium, whereas cerebellar GLUC cells are high (HPA tissue IHC). | Score the identified cell populations separately and compare matched sections processed together (general IHC practice). Escalate troubleshooting when the expected cells are absent or the compartment pattern is inconsistent. |
Experiment evidence
IHC & IF images showing BACE1 staining
A00322 · IHCImmunohistochemistry Validation of BACE in Human Liver Immunohistochemical analysis of paraffin-embedded human liver tissue using anti-BACE
A00322 · IHCKD Validation of BACE in Mouse Brain (Singer et al., 2005) Characterization of the effects of lenti-siBACE1-6 expression in the brains of AP
A00322 · IFImmunofluorescence Validation of BACE in Mouse Liver Immunofluorescent analysis of 4% paraformaldehyde-fixed mouse liver tissue labeling BAC
HPA · Cerebral cortexHuman Protein Atlas IHC, Cerebral cortex. Source: https://www.proteinatlas.org/ENSG00000186318-BACE1/tissue/cerebral+cortex#imid_4031604
HPA · HippocampusHuman Protein Atlas IHC, Hippocampus. Source: https://www.proteinatlas.org/ENSG00000186318-BACE1/tissue/hippocampal+formation#imid_4031613
HPA · ColonHuman Protein Atlas IHC, Colon. Source: https://www.proteinatlas.org/ENSG00000186318-BACE1/tissue/colon#imid_4031530
HPA · LiverHuman Protein Atlas IHC, Liver. Source: https://www.proteinatlas.org/ENSG00000186318-BACE1/tissue/liver#imid_4031547
HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody CAB016358; green = BACE1, blue = nucleus, red = microtubules.
HPA · ICC-IF A-431Human Protein Atlas immunofluorescence, A-431, antibody CAB016358; green = BACE1, blue = nucleus, red = microtubules.
← swipe / scroll for more images →
Real IHC / IF data behind the staining-pattern expectations in this section.
Sample controls for BACE1 IHC & IF
🧪Run cerebellum first and look for staining in GLUC cell cytoplasm and membrane (HPA: High in cerebellar GLUC cells). Use adipose tissue adipocytes as the negative tissue (HPA: Not detected in adipocytes); on the cerebellum slide, assess other cells against background without assuming every other cell type is BACE1-negative (HPA: High in GLUC cells).
Positive control tissue: Cerebellum (GLUC cells - cytoplasm/membrane, HPA High)
Negative control tissue: Adipose tissue (HPA Not detected)
ICC-IF cell lines (HPA subcellular resource): HPA ICC-IF images show BACE1 in A-431, U-251MG, with annotated localisation: Plasma membrane (supported) (HPA subcellular).
Technical controls: Include a no-primary, secondary-only control and a primary-host- and isotype-matched control, alongside BACE1-knockout tissue or a peptide-block control if the immunizing peptide is available (standard IHC control practice). For chromogenic cerebellum IHC, block endogenous peroxidase; for IF, check tissue autofluorescence with a no-primary control (standard IHC/IF practice).
⚠️Feasibility: A target-specific fixation window or fixation effect is unreported, and the selected-SKU structured fixative field is unreported (selected-SKU caption: fixative field unreported). The paraffin-section example uses heat retrieval in citrate buffer at pH 6, but does not establish that retrieval is required (selected-SKU caption: citrate retrieval). No supplied comparison establishes that frozen sections or IF are easier; cerebellar autofluorescence should be checked if using IF (HPA: High in cerebellar GLUC cells; standard IF practice).
HPA tissue IHC evidence for BACE1
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Approved — Low consistency between antibody staining and RNA expression data.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Cerebellum | GLUC cells - cytoplasm/membrane | High | Protein (IHC) | HPA → |
| Adrenal gland | Glandular cells | Medium | Protein (IHC) | HPA → |
| Appendix | Glandular cells | Medium | Protein (IHC) | HPA → |
| Bronchus | Respiratory epithelial cells | Medium | Protein (IHC) | HPA → |
| Caudate | Glial cells | Medium | Protein (IHC) | HPA → |
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Breast | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Cervix | Squamous epithelial cells | Not detected | Protein (IHC) | HPA → |
| Ovary | Ovarian stroma cells | Not detected | Protein (IHC) | HPA → |
| Salivary gland | Glandular cells | Not detected | Protein (IHC) | HPA → |
Section 3
Advanced BACE1 IHC Tips
Troubleshoot BACE1 staining in paraffin sections by checking retrieval, cellular pattern, controls and scoring before interpreting chromogenic signal.
Which retrieval condition should I try first for weak BACE1 staining?
Start with heat-mediated citrate buffer at pH 6 for BACE1 paraffin sections (datasheet A00322). The selected IHC image used this retrieval condition with 2 µg/ml primary antibody, so use it as the reference when comparing weak staining (caption A00322). Compare retrieval duration on adjacent sections while keeping primary incubation and detection constant; excessive heating can damage morphology (standard IHC practice). Include a known staining control such as cerebellum, where GLUC cells show high cytoplasmic or membrane signal (HPA tissue IHC). If signal remains weak, assess fixation history and antibody concentration before testing another retrieval buffer (standard IHC practice).
How should I troubleshoot fixation-related loss of BACE1 signal?
BACE1-specific sensitivity to fixation is unknown from the supplied evidence; do not infer it from tissue staining patterns or protein topology. Record fixative, fixation duration and processing for every specimen, then compare sections processed together when investigating weak signal (standard IHC practice). Use the same pH 6 citrate retrieval and primary concentration across that comparison to isolate the processing variable (datasheet A00322; standard IHC practice). Check morphology and a same-run control before raising antibody concentration, because tissue damage and weak antigen staining require different remedies (standard IHC practice). Document any change to fixation as a local validation result, rather than a known BACE1 requirement (standard IHC practice).
Which subcellular staining pattern is plausible for BACE1 in IHC?
Expect granular cytoplasmic staining with possible membrane signal, while evaluating the pattern within identified cell types (HPA tissue IHC). BACE1 is predominantly in the later Golgi and trans-Golgi network, with smaller pools in endosomes, endoplasmic reticulum and at the cell surface (UniProt P56817 localisation). Its membrane anchor spans residues 458–478, leaving a large extracellular or luminal region and a short cytoplasmic tail (UniProt P56817 topology). Cerebellar GLUC cells show high cytoplasmic or membrane staining, whereas cortical neuronal cells show medium staining in the supplied tissue panel (HPA tissue IHC). Treat isolated nuclear colour as suspect and check the counterstain and detection controls (standard IHC practice).
Could epitope position explain differences between BACE1 antibodies?
Map each antibody’s stated immunogen or epitope before comparing staining patterns; the supplied record alone does not establish the catalog antibody’s epitope. BACE1 has 6 listed isoforms, and its precursor loses a 1–21 signal peptide and 22–45 propeptide during processing (UniProt P56817 processing; UniProt P56817 isoforms). Its 458–478 membrane segment separates the large extracellular or luminal region from the 479–501 cytoplasmic tail (UniProt P56817 topology). Four listed glycosylation sites occur at residues 153, 172, 223 and 354; epitope accessibility can depend on processing and tissue preparation (UniProt P56817 glycosylation; standard IHC practice). Resolve discordant antibodies with epitope documentation and a shared tissue control (standard IHC practice).
How should I adapt a BACE1 tissue question to multiplex IF?
For multiplex IF, pair BACE1 with a marker identifying the expected cell population, such as a neuronal marker when examining cortical neuronal staining (HPA tissue IHC; standard IF practice). Include single-colour controls and choose fluorophores after checking tissue autofluorescence in an unstained section; a spectrally separated, longer-wavelength channel may improve contrast (standard IF practice). Select permeabilisation according to the antibody’s documented epitope: the 22–457 region is extracellular or luminal, while residues 479–501 form the cytoplasmic tail (UniProt P56817 topology; standard IF practice). Validate staining and permeabilisation for IF separately; the supplied catalog image documents chromogenic paraffin IHC (caption A00322). HPA reports supported plasma-membrane localisation in ICC/IF, which can guide image review (HPA subcellular).
What should I change when BACE1 staining is diffuse or widespread?
First compare the section with a no-primary control and inspect whether colour follows tissue edges, damaged regions or endogenous pigment (standard IHC practice). For HRP detection, apply a peroxidase block and assess the control before interpreting diffuse DAB signal as BACE1 (standard IHC practice). Titrate the primary downward or shorten development if background rises across cell types, while retaining a same-run positive control (standard IHC practice). The selected image used 2 µg/ml primary antibody, 10% serum block for 1 hour, and overnight primary incubation at 4°C (caption A00322). Evaluate residual staining against BACE1’s granular cytoplasmic and membrane-associated distribution (HPA tissue IHC; UniProt P56817 localisation).
How can I score BACE1 IHC across specimens consistently? ⚠ ANSWER MARKED FOR VERIFICATION
Define the anatomical region and cell population before scoring, then apply identical imaging and DAB assessment settings to every section (standard IHC practice). An H-score combines the percentage of cells at each intensity; alternatively report % positive cells or positive-cell density per mm² when intensity is unreliable (standard IHC practice). Normalise cell counts to the number of evaluable target cells or measured tissue area, and exclude folds, necrosis and section edges using predefined rules (standard IHC practice). Score granular cytoplasmic and membrane-associated signal separately if those compartments answer different questions (HPA tissue IHC; standard IHC practice). Keep control sections and threshold settings consistent because HPA reports low consistency between staining and RNA expression (HPA tissue IHC).
When is apparent BACE1 positivity more likely to be artefact?
Judge positivity by cell identity, compartment, morphology and the no-primary control together (standard IHC practice). Granular cytoplasmic or membrane staining is plausible, and BACE1 is predominantly associated with the trans-Golgi network, with additional endosomal and cell-surface pools (HPA tissue IHC; UniProt P56817 localisation). Be cautious with isolated nuclear colour, staining restricted to cut edges or necrotic areas, or signal persisting in the no-primary HRP control; check endogenous peroxidase blocking (standard IHC practice). Compare with an expected population such as cerebellar GLUC cells, reported as high, and adipocytes, reported as not detected (HPA tissue IHC). Do not treat intensity alone as confirmation: HPA reports low consistency between antibody staining and RNA expression (HPA tissue IHC).
Boster reagents
Best BACE1 / Beta-secretase 1 IHC Antibodies
A00322 has IHC data from human paraffin-embedded liver and IF data from mouse liver tissue (A00322 IHC and IF image captions).
Real IHC data
Anti-BACE BACE1 Antibody
Cat # A00322
A00322 shows human paraffin-embedded liver IHC at 2 μg/mL, with formaldehyde fixation and citrate pH 6 heat retrieval (A00322 IHC image caption). The same SKU shows IF in 4% paraformaldehyde-fixed mouse liver at 10 μg/mL (A00322 IF image caption).
Which to pick: Choose A00322 for tissue IHC in human paraffin-embedded sections; its own IHC caption documents formaldehyde fixation and citrate pH 6 heat retrieval (A00322 IHC image caption). For IF, A00322 has mouse liver tissue data; the payload provides no ICC validation (A00322 IF image caption; catalog applications). Its rabbit polyclonal format and Human/Mouse reactivity make it the cross-species candidate, with application-specific validation listed for human IHC and mouse IF (catalog antibody description and validation notes).
Each figure is that product's own IHC / IF validation image from its datasheet.
References
- UniProt Consortium. UniProt entry P56817 (BACE1_HUMAN, Beta-secretase 1).
- Human Protein Atlas. BACE1 tissue IHC expression (reliability: Approved).
- Human Protein Atlas. BACE1 subcellular location (ICC-IF): Localized to the plasma membrane..
- Human Protein Atlas. BACE1 antibody validation summary (1 antibodies).
- BACE1 in the retina: a sensitive biomarker for monitoring early pathological changes in Alzheimer's disease. Neural regeneration research 2016 — PMC4829010.
- β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation. The European journal of neuroscience 2010 — PMC2970759.
- BACE1 Regulates Proliferation and Neuronal Differentiation of Newborn Cells in the Adult Hippocampus in Mice. eNeuro 2018 — PMC6073981.
- Identification and Analysis of Axolotl Homologs for Proteins Implicated in Human Neurodegenerative Proteinopathies. Genes 2024 — PMC10969905.
- PubMed PMID:10531052 — UniProt-cited evidence.
- PubMed PMID:10591214 — UniProt-cited evidence.
- PubMed PMID:10591213 — UniProt-cited evidence.
Immunohistochemistry protocol sheet for BACE1 (Beta-secretase 1). Expected localisation Granular cytoplasm (HPA tissue IHC); TGN expected (UniProt). Antigen retrieval: Citrate pH 6 HIER, heat-mediated (datasheet A00322). Validated IHC antibody: A00322 at 1-2 μg/mL (the product's own IHC validation image is shown). Controls (HPA): positive Cerebellum (GLUC cells - cytoplasm/membrane); negative Adipose tissue. IHC-P workflow on paraffin sections. Protocol steps: 1. Sample: Formaldehyde-fixed, paraffin-embedded human liver tissue (datasheet A00322); 2. Fixation: Image formalin-fixed; duration unreported (datasheet A00322); verify before use.; 3. Sectioning: 4–5 µm sections on charged slides (standard); 4. Deparaffinisation: Xylene, graded ethanol series to water (standard); 5. Antigen retrieval: Heat retrieval: Citrate pH 6 (datasheet A00322); 20 min, 95–100 °C (standard); 6. Peroxidase block: 3% H2O2, 10 min , room temperature (standard); 7. Blocking: 10% serum (datasheet A00322); 8. Primary antibody: Rabbit anti-BACE1, 1-2 μg/mL (datasheet A00322); 9. Primary incubation: Overnight at 4 °C (standard). Watch for: Fixation: Use consistent formaldehyde fixation (datasheet A00322 IHC). (selected-SKU IHC image A00322); Caveat: Staining has low consistency with RNA expression (HPA tissue IHC); Isoform / epitope: 6 isoforms; map the epitope to its extracellular or cytoplasmic side (UniProt); Regulation: Higher expression in brain and pancreas (UniProt). Evidence: UniProt P56817, HPA tissue IHC · Approved, HPA ICC-IF · plasma membrane., Datasheet A00322, PMC4829010, PMC6073981. QR code links to https://www.bosterbio.com/bosterbio-gene-info-cards/BACE1/immunohistochemistry-ihc-guide.